Tenable Holdings (NASDAQ:TENB) Stock, Quote.Headers.trade-ideas

Tenable Holdings

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

Konskie,,Poland,-,May,12,,2024:,Tenable,Company,Logo,Displayed

News

Markets

TENB

Amit Yoran, the CEO and chairman of Tenable Holdings, died on Friday at age 54.

Tenable Holdings CEO Amit Yoran Dies at 54

Carvana

Pre-Market Outlook

Movers

Trading Ideas

ALXO

ATEC

BBLG

CDNA

CFLT

CVNA

MASSIVE INTERACTIVE NV by Massive Interactive, Inc.

HUGE

IMRX

KXIN

NCNC

NOVA

TDOC

UDMY

Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

xr:d:DAFibNgallc:2,j:46766421678,t:23050912

HSBC

Western Digital, Udemy, Teladoc Health And Other Big Stocks Moving Lower In Thursday&#39;s Pre-Market Session

Tenable Holdings Inc

Scotiabank analyst Patrick Colville maintains MongoDB (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) with a Sector Perform and lowers the price target from $350 to $275.

Price Target

Analyst Ratings

Scotiabank Maintains Sector Perform on MongoDB, Lowers Price Target to $275

Scotiabank analyst Patrick Colville maintains Fortinet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTNT#NASDAQ">FTNT</a>) with a Sector Outperform and raises the price target from $110 to $115.

FTNT

Scotiabank Maintains Sector Outperform on Fortinet, Raises Price Target to $115

Scotiabank analyst Patrick Colville maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Sector Outperform and lowers the price target from $135 to $127.

ESTC

Scotiabank Maintains Sector Outperform on Elastic, Lowers Price Target to $127

WIIM

INTC

Intel shares are trading higher after HSBC upgraded the stock from Reduce to Hold.

Scotiabank analyst Patrick Colville maintains CyberArk Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) with a Sector Outperform and raises the price target from $340 to $400.

CYBR

Scotiabank Maintains Sector Outperform on CyberArk Software, Raises Price Target to $400

Whales with a lot of money to spend have taken a noticeably bullish stance on Hims &amp; Hers Health.
Looking at options history for Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) we detected 20 trades.
If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish expectations and 35% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $315,490 and 15, calls, for a total amount of $738,711.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $40.0 for Hims &amp; Hers Health over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Hims &amp; Hers Health's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims &amp; Hers Health's whale activity within a strike price range from $15.0 to $40.0 in the last 30 days. 
<h3>Hims &amp; Hers Health 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737485150_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/14/25</td>
<td>$2.5</td>
<td>$2.34</td>
<td>$2.48</td>
<td>$30.00</td>
<td>$123.5K</td>
<td>374</td>
<td>1.8K</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/14/25</td>
<td>$2.56</td>
<td>$2.43</td>
<td>$2.48</td>
<td>$30.00</td>
<td>$123.5K</td>
<td>374</td>
<td>1.1K</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.96</td>
<td>$1.82</td>
<td>$1.95</td>
<td>$15.00</td>
<td>$97.1K</td>
<td>4.1K</td>
<td>3.0K</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1.88</td>
<td>$1.86</td>
<td>$1.88</td>
<td>$15.00</td>
<td>$94.0K</td>
<td>4.1K</td>
<td>1.4K</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/14/25</td>
<td>$2.45</td>
<td>$2.44</td>
<td>$2.45</td>
<td>$30.00</td>
<td>$56.6K</td>
<td>374</td>
<td>593</td>
</tr>
</tbody>
</table>

<h3>About Hims &amp; Hers Health</h3>
Hims &amp; Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
In light of the recent options history for Hims &amp; Hers Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Hims &amp; Hers Health</h3>
<ul>
<li>With a volume of 7,671,616, the price of HIMS is up 6.7% at $29.71. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 34 days.</li>
</ul>
<h3>What Analysts Are Saying About Hims &amp; Hers Health</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $28.75.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler has decided to maintain their Neutral rating on Hims &amp; Hers Health, which currently sits at a price target of $24. 
&#x2A; An analyst from Needham persists with their Buy rating on Hims &amp; Hers Health, maintaining a target price of $31. 
&#x2A; An analyst from Citigroup has revised its rating downward to Sell, adjusting the price target to $25. 
&#x2A; In a cautious move, an analyst from BTIG downgraded its rating to Buy, setting a price target of $35. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Hims &amp; Hers Health options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Options

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Hims & Hers Health Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on SoundHound AI.
Looking at options history for SoundHound AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) we detected 20 trades.
If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 45% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $782,901 and 12, calls, for a total amount of $609,727.
<h3>What's The Price Target?</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $5.5 to $26.0 for SoundHound AI over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for SoundHound AI's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of SoundHound AI's whale activity within a strike price range from $5.5 to $26.0 in the last 30 days. 
<h3>SoundHound AI Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737485145_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SOUN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$4.9</td>
<td>$4.85</td>
<td>$4.9</td>
<td>$18.00</td>
<td>$356.7K</td>
<td>25</td>
<td>1.0K</td>
</tr>
<tr>
<td>SOUN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$5.1</td>
<td>$5.05</td>
<td>$5.1</td>
<td>$12.00</td>
<td>$190.7K</td>
<td>2.5K</td>
<td>52</td>
</tr>
<tr>
<td>SOUN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$4.9</td>
<td>$4.85</td>
<td>$4.9</td>
<td>$18.00</td>
<td>$133.2K</td>
<td>25</td>
<td>303</td>
</tr>
<tr>
<td>SOUN</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/24/25</td>
<td>$8.6</td>
<td>$8.4</td>
<td>$8.5</td>
<td>$24.00</td>
<td>$127.5K</td>
<td>313</td>
<td>163</td>
</tr>
<tr>
<td>SOUN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$3.35</td>
<td>$3.25</td>
<td>$3.35</td>
<td>$15.00</td>
<td>$60.3K</td>
<td>592</td>
<td>499</td>
</tr>
</tbody>
</table>

<h3>About SoundHound AI</h3>
SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers.
Having examined the options trading patterns of SoundHound AI, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of SoundHound AI</h3>
<ul>
<li>With a trading volume of 65,236,287, the price of SOUN is up by 12.75%, reaching $15.38.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 37 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for SoundHound AI</h3>
A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $20.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from HC Wainwright &amp; Co. lowers its rating to Buy with a new price target of $26. 
&#x2A; Consistent in their evaluation, an analyst from HC Wainwright &amp; Co. keeps a Buy rating on SoundHound AI with a target price of $26. 
&#x2A; Maintaining their stance, an analyst from Northland Capital Markets continues to hold a Market Perform rating for SoundHound AI, targeting a price of $8. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for SoundHound AI, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

SOUN

Unpacking the Latest Options Trading Trends in SoundHound AI

Whales with a lot of money to spend have taken a noticeably bearish stance on Snowflake.
Looking at options history for Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) we detected 70 trades.
If we consider the specifics of each trade, it is accurate to state that 34% of the investors opened trades with bullish expectations and 51% with bearish.
From the overall spotted trades, 12 are puts, for a total amount of $1,174,639 and 58, calls, for a total amount of $5,527,308.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $60.0 and $300.0 for Snowflake, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Snowflake's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Snowflake's whale activity within a strike price range from $60.0 to $300.0 in the last 30 days. 
<h3>Snowflake Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737485140_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$126.6</td>
<td>$121.7</td>
<td>$121.7</td>
<td>$60.00</td>
<td>$523.9K</td>
<td>45</td>
<td align="right">77</td>
</tr>
<tr>
<td>SNOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$70.45</td>
<td>$66.0</td>
<td>$70.45</td>
<td>$230.00</td>
<td>$338.1K</td>
<td>0</td>
<td align="right">51</td>
</tr>
<tr>
<td>SNOW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$38.55</td>
<td>$35.8</td>
<td>$38.55</td>
<td>$180.00</td>
<td>$211.8K</td>
<td>9</td>
<td align="right">97</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$3.75</td>
<td>$3.65</td>
<td>$3.6</td>
<td>$210.00</td>
<td>$198.0K</td>
<td>4.7K</td>
<td align="right">587</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$88.3</td>
<td>$84.9</td>
<td>$84.9</td>
<td>$110.00</td>
<td>$144.3K</td>
<td>81</td>
<td align="right">17</td>
</tr>
</tbody>
</table>

<h3>About Snowflake</h3>
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that went public in 2020. To date, the company has over 3,000 customers, including nearly 30% of the Fortune 500. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to buy and ingest data, while its data solutions can be hosted on various public clouds.
<h3>Snowflake's Current Market Status</h3>
<ul>
<li>Trading volume stands at 3,019,870, with SNOW's price up by 2.36%, positioned at $174.81.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 36 days.</li>
</ul>
<h3>Expert Opinions on Snowflake</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $200.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $201. 
&#x2A; Showing optimism, an analyst from Wells Fargo upgrades its rating to Overweight with a revised price target of $200. 
&#x2A; Maintaining their stance, an analyst from Loop Capital continues to hold a Buy rating for Snowflake, targeting a price of $205. 
&#x2A; Showing optimism, an analyst from Barclays upgrades its rating to Overweight with a revised price target of $190. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Snowflake with a target price of $208. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Snowflake options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

SNOW

Looking At Snowflake's Recent Unusual Options Activity

Scotiabank analyst Patrick Colville maintains Cloudflare (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>) with a Sector Perform and raises the price target from $87 to $110.

Scotiabank Maintains Sector Perform on Cloudflare, Raises Price Target to $110

Scotiabank analyst Brandon Bingham maintains Kinetik Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNTK#NYSE">KNTK</a>) with a Sector Outperform and lowers the price target from $64 to $62.

KNTK

Scotiabank Maintains Sector Outperform on Kinetik Holdings, Lowers Price Target to $62

On Monday, the European Commission approved GSK plc&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) Jemperli&nbsp;(dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult patients with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy.
The <a target="_blank" href="https://www.gsk.com/en-gb/media/press-releases/european-commission-expands-jemperli-dostarlimab-plus-chemotherapy-approval-to-all-adult-patients-with-primary-advanced-or-recurrent-endometrial-cancer/" rel="noreferrer noopener">approval</a> broadens the previous indication for&nbsp;Jemperli&nbsp;plus chemotherapy in the European Union (EU) to include patients with mismatch repair proficient (MMRp)/microsatellite stable (MSS) tumors, which represent approximately 75% of patients diagnosed with endometrial cancer and who have limited treatment options.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/01/43010436/gsk-highlights-new-approvals-vaccine-momentum-at-jp-morgan-healthcare-conference" rel="noreferrer noopener">GSK Highlights New Approvals, Vaccine Momentum At JPMorgan Healthcare Conference</a>
The European Commission&#8217;s approval to expand the use of&nbsp;Jemperli&nbsp;plus chemotherapy is based on results from Part 1 of the RUBY phase 3 trial.
The company says RUBY Part 1 is the only clinical trial in this setting to show a clinically meaningful and statistically significant overall survival benefit in the full population of patients with primary advanced or recurrent endometrial cancer, showing a 31% reduction in risk of death compared to chemotherapy alone.
At the 2.5-year landmark, the chance of being alive was 61% for the&nbsp;Jemperli&nbsp;plus chemotherapy group (245 patients) compared to 49% in the chemotherapy group (249 patients).
In addition, a 16.4-month improvement in median OS was observed with Jemperli plus chemotherapy versus chemotherapy alone. The median duration of follow-up was more than three years.
The safety and tolerability analysis from RUBY Part 1 showed a safety profile for&nbsp;Jemperli&nbsp;plus carboplatin-paclitaxel that was generally consistent with the known safety profiles of the individual agents.
The label for&nbsp;Jemperli&nbsp;plus chemotherapy in the U.S. was expanded to all adult patients with primary advanced or recurrent endometrial cancer in August 2024.
Recently, GSK agreed to acquire&nbsp;IDRx, Inc., a biopharmaceutical company focused on precision therapeutics for&nbsp;gastrointestinal stromal tumors, <a target="_blank" href="https://www.benzinga.com/25/01/42950025/gsk-to-buy-us-based-stomach-cancer-drug-developer-for-over-1-billion" rel="noreferrer noopener">for $1 billion</a>.
Price Action: GSK stock is up 0.76% at $33.69 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43102213/whats-going-on-with-the-stock-of-foresight-autonomous-today" target="_blank" rel="noreferrer noopener">Foresight Autonomous Inks Commercial Cooperation Pact With Autonomous Drone Manufacturer: Details</a></li>
</ul>
Photo by HJBC via Shutterstock.

Biotech

Equities

Large Cap

Health Care

General

Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer

Trump Media & Technology shares are trading lower following Donald Trump's inauguration.

Scotiabank analyst Brandon Bingham maintains Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) with a Sector Outperform and raises the price target from $242 to $247.

Scotiabank Maintains Sector Outperform on Cheniere Energy, Raises Price Target to $247

Scotiabank analyst Patrick Colville maintains Check Point Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>) with a Sector Outperform and raises the price target from $200 to $215.

CHKP

Scotiabank Maintains Sector Outperform on Check Point Software, Raises Price Target to $215

Scotiabank analyst Orest Wowkodaw maintains Capstone Copper (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CS#TSX">CS</a>) with a Sector Outperform and lowers the price target from C$12 to C$11.

TSX:CS

Scotiabank Maintains Sector Outperform on Capstone Copper, Lowers Price Target to C$11

PTON

Peloton Interactive Option Alert: Mar 21 $9 Calls at the Ask: 5000 @ $1.02 vs 998 OI; Earnings 2/3 Before Open [est] Ref=$8.435

On Monday, BrightSpring Health Services Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>) agreed to sell its Community Living business, ResCare Community Living, to Sevita for <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g43087445/brightspring-health-services-inc-enters-into-definitive-agreement-to-divest-community-living-busin" rel="noreferrer noopener">$835 million in cash</a>.
The deal, set to close in 2025, aligns with BrightSpring&#8217;s strategic focus on enhancing its core services, including home health, hospice, primary care, rehabilitation, and pharmacy solutions.
After the divestiture, the company expects to realize additional operational efficiencies across the BrightSpring platform, with a more synergistic overall portfolio of service offerings. The transaction is expected to be accretive to both Company and Provider Services Revenue growth and Adjusted EBITDA growth.
Post-sale, BrightSpring expects its Provider Services portfolio to exhibit stronger revenue growth and adjusted EBITDA, supported by an optimized payer mix and a focus on high-demand growth markets.
The company also anticipates accelerated deleveraging, aiming to reduce its long-term debt-to-EBITDA ratio to below 3.0x.
The Community Living business, which generated approximately $1.2 billion in revenue and $128 million in adjusted EBITDA in 2024, includes&nbsp;14,000 clients and 13,500 employees. BrightSpring anticipates after-tax proceeds of $715 million, which will be primarily allocated toward debt reduction, improving the company&#8217;s financial position.
The company reported preliminary 2024 sales of $11.2 billion-$11.3 billion, or a year over year increase of 26.9%- 28.0%, compared to <a href="https://www.benzinga.com/calendars/guidance">consensus of $11.17 billion.</a>
<ul>
<li>Pharmacy Segment Revenue is expected to be $8.7 billion-$8.75 billion.</li>
<li>Provider Segment Revenue of $2.5 billion-$2.55 billion; Community Living Revenue in 2024 is expected to be $1.2 billion.</li>
<li>Adjusted EBITDA is expected to be approximately $588 million, with Community Living Adjusted EBITDA of approximately $128 million.</li>
</ul>
For 2025, the company expects sales of $11.5 billion-$12 billion compared to a consensus of $12.39 billion.
<ul>
<li>Pharmacy Segment Revenue of $10.05 billion-$10.5 billion and Provider Segment Revenue of $1.45 billion-$1.5 billion.</li>
<li>Adjusted EBITDA of $540 million- $555 million.</li>
</ul>
Price Action: BTSG stock is up 13.6% at $21.08 at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/43102451/valneva-chikungunya-vaccine-shows-high-sustained-immune-response-in-adolescents-one-year-after-single-shot" target="_blank" rel="noreferrer noopener">Valneva Vaccine Shows Sustained Immune Response In Adolescents One Year After Single Shot</a></li>
</ul>
Photo via Shutterstock.

Guidance

Asset Sales

BTSG

BrightSpring Health Divests Community Living Business For $850 Million To Focus On Core Activities

Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) is set to report its fourth-quarter financial results after Tuesday's closing bell. Here's a look at what investors will be watching when the financial <a href="https://www.benzinga.com/general/market-summary/25/01/42871340/regional-banks-can-thrive-despite-big-bank-dominance-truist-securities-highlights-three-key-paths-for-thriving-regional-banks">services company reports. </a>
What To Know: Wall Street will be interested in the performance of Capital One&#8217;s credit card segment, particularly its domestic card business. Net charge-off rates and delinquency rates are often seen as a barometer for the health of the U.S. consumer. 
Read Next: <a href="https://www.benzinga.com/news/large-cap/25/01/43106379/trump-reverses-bidens-ai-policies-on-day-1-what-it-means-for-tech-giants-nvidia-amd-alphabet">Trump Reverses Biden&#8217;s AI Policies On Day 1: What It Means For Tech Giants Nvidia, AMD, Alphabet&nbsp;</a>
Rising charge-offs and delinquency rates may also be a point of concern for investors, as they could potentially lead to higher losses for Capital One in the future. The company reported its net charge-off rate was 5.6% in the third quarter, slightly above analyst estimates of 5.5% and the 30-plus day performing delinquency rate for the overall portfolio was 3.71% in the third quarter, up from 3.42% in the previous quarter. 
According to estimates from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, analysts expect Capital One Financial to report earnings of $2.82 per share and quarterly revenue of $10.21 billion after Tuesday's closing bell.&nbsp;
What Else: Investors will also be looking for any comments or financial impacts related to <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42981370/cfpb-sues-capital-one-over-alleged-2-billion-in-lost-interest-for-consumers">the recent lawsuit</a> filed by the Consumer Financial Protection Bureau regarding interest rates on its savings accounts.&nbsp;
The CFPB's lawsuit alleges Capital One deliberately misled customers by hiding its more lucrative 360 Performance Savings account while falsely advertising its 360 Savings account as offering one of the best interest rates in the nation.&nbsp;
COF Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Capital One shares are up 1.25% at $193.34 at the time of publication Tuesday. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/initiation/25/01/43102452/roku-analyst-sees-25-upside-as-tv-ad-dollars-go-digital">Roku Analyst Sees 25% Upside As TV Ad Dollars Go Digital&nbsp;</a></li>
</ul>
Image: Shutterstock

Earnings

Previews

Legal

Capital One To Report Q4 Results: Here's What To Watch

Scotiabank analyst Tanya Jakusconek maintains Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) with a Sector Perform and lowers the price target from $52 to $50.

Scotiabank Maintains Sector Perform on Newmont, Lowers Price Target to $50

Binary Options

QBTS

D-Wave Quantum Option Alert: Jan 31 $7.5 Calls Sweep (6) near the Ask: 840 @ $0.351 vs 2126 OI; Ref=$6.125

Tenable (TENB) has announced the passing of its Chairman and Chief Executive Officer, Amit Yoran. The executive passed away unexpectedly on Friday....

Tenable announces passing of Chairman, CEO Amit Yoran

Tenable Holdings ( ($TENB) ) has shared an update. Tenable Holdings announced the passing of its Chairman and CEO, Amit Yoran, who was a prominent ...

Tenable Holdings Announces Leadership Transition After CEO's Passing

Atlassian, Datadog see rating changes at Truist, firm highlights sector outlook

Top stocks in software as Wolfe sees it as an area of M&A opportunities

The software industry is poised for continued expansion with the rapid pace of digital transformation across all industries. Amid this backdrop, it could be wise to invest in mid-cap software stocks, such as Open Text Corp (OTEX), Tenable Holdings (TENB), and Commvault Systems (CVLT), with significant upside potential. Continue reading… Technology has become an essential component of an organization's digital strategy, and the transition to public cloud services has resulted in revenue stability. Customer and employee experience, data-driven decision-making, and automation are three major themes driving the software market.
Thus, investors could consider investing in fundamentally sound mid-cap software stocks: Open Text Corporation (<a href="https://stocknews.com/stock/OTEX/">OTEX</a>), Tenable Holdings, Inc. (<a href="https://stocknews.com/stock/TENB/">TENB</a>), and Commvault Systems, Inc. (<a href="https://stocknews.com/stock/CVLT/">CVLT</a>), with significant upside potential.
Businesses rely on software solutions to streamline operations, improve customer experiences, obtain data-driven insights, and safeguard their systems as they adapt to and compete in the dynamic digital landscape. The U.S. software market is estimated to grow at a <a href="https://www.marknteladvisors.com/research-library/us-software-market.html">CAGR of 7.2%</a> by 2024.
<a href="https://www.businesswire.com/news/home/20241104858331/en/Application-Software-Market-Research-Report-2024-2030-with-Analyst-Recommendations---Embrace-and-Lead-in-Innovation-Optimize-Pricing-Models---ResearchAndMarkets.com">Artificial intelligence (AI) and Machine Learning (ML)</a> are also playing a transformative role in the application software market. AI-powered applications are increasingly integrated into business processes to automate tasks, enhance decision-making, and deliver personalized experiences. 
Considering these factors, let's take a look at the fundamentals of the three software stock picks.
Open Text Corporation (<a href="https://stocknews.com/stock/OTEX/">OTEX</a>)
Valued at $7.57 billion by market cap, OTEX engages in the provision of information management products and services. The company offers content services, including content collaboration and intelligent capture, as well as records management, collaboration, e-signatures, and archiving.
In terms of the trailing-12-month <a href="https://www.investopedia.com/terms/e/ebitda-margin.asp">EBITDA margin</a>, OTEX's 27.78% is 167.7% higher than the 10.38% industry average. Likewise, its 76.56% trailing-12-month gross profit margin is 50.2% higher than the 50.98% industry average. Its 18.45% trailing-12-month EBIT margin is 242.9% higher than the 5.38% industry average.
In terms of forward non-GAAP P/E, OTEX is trading at 7.74x, 69.5% lower than the industry average of 25.36x. Likewise, the stock's forward Price/Sales multiple of 1.40 is 57.1% lower than the industry average of 3.25. Also, its forward EV/EBITDA of 7.32x is 52.6% lower than the industry average of 15.46x.
OTEX's cloud services and subscriptions for the fiscal first quarter that ended on September 30, 2024, rose 1.3% year-over-year to $457 million. Similarly, the company's net income and EPS are at $84 million and $0.32 per share, up 4.3% and 6.7% over the prior-year quarter, respectively.
Street expects OTEX's EPS and revenue for the year ending June 30, 2024, to increase 13.6% and 2.4% year-over-year to $4.15 and $5.44 billion, respectively. It surpassed the consensus EPS estimates in three of the trailing four quarters.
The stock has gained marginally intraday to close the last trading session at $28.42.
Based on seven Wall Street analysts offering 12-month price targets for OTEX in the last three months, <a href="https://www.tipranks.com/stocks/otex/forecast">the average target price is $34.71</a>, indicating a 22.1% change from the last price, with a high forecast of $38 and a low forecast of $32.
OTEX's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect its robust outlook. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.
It has an A grade for Value and a B for Growth. It is ranked #16 out of 125 stocks in the <a href="https://stocknews.com/category/software-application/">Software - Application</a> industry.
Beyond what is stated above, we've also rated OTEX for Stability, Momentum, Sentiment, and Quality. Get all OTEX ratings <a href="https://stocknews.com/stock/OTEX/">here</a>.
Tenable Holdings, Inc. (<a href="https://stocknews.com/stock/TENB/">TENB</a>)
Valued at $4.72 billion by market cap, TENB provides cyber exposure solutions in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and Japan. Its platforms include Tenable Vulnerability Management and Tenable Cloud Security.
TENB's 77.55% trailing-12-month gross profit margin is 52.1% higher than the 50.98% industry average. Its 21.70% trailing-12-month levered FCF margin is 91.9% higher than the 11.31% industry average.
During the fiscal third quarter that ended September 30, 2024, TENB's revenue increased 13% year-over-year to $227.09 million. Its gross profit grew 2.4% from the year-ago value to $176.59 million. In addition, the company's non-GAAP net income and non-GAAP net income per share came in at $39.32 million and $0.32, up 42.1% and 39.1% over the prior-year quarter, respectively.
Street expects TENB's revenue for the fiscal fourth quarter (ending December 31, 2024) to increase 8.7% year-over-year to $231.81 million. Its EPS for the same quarter is expected to increase 37.8% year-over-year to $0.34. It surpassed Street's revenue and EPS estimates in all of the trailing four quarters, which is impressive.
Over the past three months, the stock has plunged 3% to close the last trading session at $39.29.
Based on 14 Wall Street analysts offering 12-month price targets for TENB in the last three months, <a href="https://www.tipranks.com/stocks/tenb/forecast">the average target price is $49.50</a>, indicating a 26% change from the last price, with a high forecast of $55 and a low forecast of $44.
TENB's robust fundamentals are reflected in its POWR Ratings. It has an overall rating of B, which equates to a Buy in our proprietary rating system.
The stock has an A grade for Growth. TENB is ranked #4 out of 20 stocks in the B -rated <a href="https://stocknews.com/category/software-security/">Software - Security</a> industry.
<a href="https://stocknews.com/stock/TENB/">Click here</a> to access the additional TENB ratings (Value, Quality, Sentiment, Momentum, and Stability).
Commvault Systems, Inc. (<a href="https://stocknews.com/stock/CVLT/">CVLT</a>)
Valued at $6.61 billion by market cap, CVLT provides a platform that enhances cyber resiliency by protecting the data in the United States and internationally. The company offers Operational Recovery and Autonomous Recovery.
CVLT's 80.09% trailing-12-month gross profit margin is 61% higher than the 50.98% industry average. Its 9.64% trailing-12-month EBIT margin is 79.1% higher than the 5.38% industry average.
In terms of forward non-GAAP P/E, CVLT is trading at 44.77x, 76.1% lower than the industry average of 25.42x. Likewise, the stock's forward Price/Sales multiple of 7.04 is 116.6% lower than the industry average of 3.25. Also, its forward EV/EBITDA of 31.28x is 101% lower than the industry average of 15.56x.
In the fiscal second quarter ended September 30, 2024, CVLT's total revenues reached $233.28 million, up 7.8% year-over-year. Moreover, net income and net income per share stood at $ 15.57 million and $0.35, respectively, representing increases of 15.1% and 13.9% over the prior-year quarter.
Street expects CVLT's revenue and EPS for the third quarter ending December 31, 2024, to increase 13.4% and 12.1% year-over-year to $245.81 million and $ 0.87, respectively. It surpassed Street revenue and EPS estimates in all of the trailing four quarters.
Over the past year, the stock has gained 89.3% to close the last trading session at $151.19.
Based on five Wall Street analysts offering 12-month price targets for TENB in the last three months, <a href="https://www.tipranks.com/stocks/cvlt/forecast">the average target price is $175.50</a>, indicating a 16.1% change from the last price, with a high forecast of $200 and a low forecast of $140.
CVLT's POWR Ratings reflect bright prospects. The stock has an overall rating of B, which equates to a Buy in our proprietary rating system.
The stock has an A grade for Quality. CVLT is ranked #18 out of 125 stocks in the B-rated <a href="https://stocknews.com/category/software-application/">Software - Application</a> industry.
In addition to the POWR Ratings highlighted above, one can access CVLT's ratings (Momentum, Growth, Value, Stability, and Sentiment) <a href="https://stocknews.com/stock/CVLT/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
OTEX shares were trading at $28.25 per share on Tuesday afternoon, down $0.17 (-0.60%). Year-to-date, OTEX has declined -29.97%, versus a 24.71% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Nidhi Agarwal</h2> <img src='https:/wp-content/uploads/2023/03/Nidhi-Agarwal_Headshot-3.jpg' style="float:left; padding:5px;width:125px;">Nidhi is passionate about the capital market and wealth management, which led her to pursue a career as an investment analyst. She holds a bachelor's degree in finance and marketing and is pursuing the CFA program.

Her fundamental approach to analyzing stocks helps investors identify the best investment opportunities.<a href="https://stocknews.com/authors/?author=nidhi-agarwal">More...</a>The post <a href=https://stocknews.com/news/otex-tenb-cvlt-3-mid-cap-software-stocks-with-massive-upside-in-2025/>3 Mid-Cap Software Stocks With Massive Upside in 2025</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Mid-Cap Software Stocks With Massive Upside in 2025

Adam Borg, an analyst from Stifel Nicolaus, has initiated a new Hold rating on Tenable Holdings (TENB). Adam Borg has given his Hold rating due to ...

Cautious Hold on Tenable Holdings Amid Market Uncertainties and Strategic Opportunities

Stifel downgraded Tenable (TENB) to Hold from Buy with a price target of $45, down from $46, following a transfer of coverage. While Tenable is a "...

Tenable downgraded to Hold from Buy at Stifel

Rapid7, Tenable cut to Hold at Stifel on low priority of vulnerability management

Scotiabank analyst Patrick Colville raised the firm's price target on Tenable (TENB) to $45 from $44 and keeps a Sector Perform rating on the share...

Tenable price target raised to $45 from $44 at Scotiabank

BASE

BLKB

CRWD

CVLT

DDOG

DOCN

FFIV

FIVN

FROG

GTLB

IGPT

INFA

JAMF

NCNO

NICE

OTEX

PANW

PAYC

PCTY

PEGA

PYCR

QLYS

TEAM

VRNS

Economics

Press Releases

Tenable Cloud Risk Report Sounds the Alarm on Toxic Cloud Exposures Threatening Global Organizations

Leading Analyst Firm Ranks Tenable #1 for Sixth Consecutive Year in Market Share for Device Vulnerability Management

Tenable Tackles Emerging Cloud and AI Risks With the Launch of Data and AI Security Posture Management for Cloud Environments

Tenable Announces Date for its Third Quarter Earnings Conference Call

Tenable Announces Third Quarter 2024 Financial Results

Tenable to Participate in Upcoming Investor Events

Tenable Adds Patch Management to Rapidly Close Security Exposures

Tenable Security Center Delivers Focused Vulnerability Prioritization to Close Critical Exposures that Increase Business Risk

Management

Tenable Announces the Passing of Chairman and CEO Amit Yoran

Tenable Announces Date For Its Fourth Quarter and Full Year 2024 Earnings Conference Call

Comments

Tenable Holdings

Tenable Holdings (TENB) Forecast

Tenable Holdings (NASDAQ:TENB) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga